| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 肠外营养药(元) | 33,716,300.00 | 23,818,390.53 | 83,549,200.00 | 55,982,937.95 |
| 抗感染药(元) | 98,571,900.00 | 49,880,908.11 | 73,770,000.00 | 50,982,157.20 |
| 消化系统药(元) | 11,022,800.00 | 7,242,431.51 | 35,610,900.00 | 32,711,170.02 |
| 其他主营业务(元) | - | - | - | 32,711,170.02 |
| 其他产品(元) | 45,999,400.00 | 27,999,272.34 | 88,858,700.00 | 58,109,663.60 |
| 其他业务(元) | - | - | - | 2,495,448.85 |
| 营业成本(元) | ||||
| 肠外营养药(元) | 16,317,500.00 | 11,995,538.46 | 31,804,400.00 | 10,592,993.52 |
| 抗感染药(元) | 77,416,700.00 | 39,582,921.64 | 45,040,300.00 | 17,716,423.24 |
| 消化系统药(元) | 1,764,700.00 | 1,129,411.60 | 5,583,700.00 | 2,525,702.13 |
| 其他主营业务(元) | - | - | - | 2,525,702.13 |
| 其他产品(元) | 3,376,300.00 | 2,038,983.82 | 5,476,100.00 | 1,389,145.57 |
| 其他业务(元) | - | - | - | 1,673,467.32 |
| 毛利(元) | ||||
| 肠外营养药(元) | 17,398,800.00 | 11,822,852.07 | 51,744,800.00 | 45,389,944.43 |
| 抗感染药(元) | 21,155,200.00 | 10,297,986.47 | 28,729,700.00 | 33,265,733.96 |
| 消化系统药(元) | 9,258,100.00 | 6,113,019.91 | 30,027,200.00 | 30,185,467.89 |
| 其他主营业务(元) | - | - | - | 30,185,467.89 |
| 其他产品(元) | 42,623,100.00 | 25,960,288.52 | 83,382,600.00 | 56,720,518.03 |
| 其他业务(元) | - | - | - | 821,981.53 |
| 毛利率(%) | ||||
| 肠外营养药(%) | 51.60 | 49.64 | 61.93 | 81.08 |
| 抗感染药(%) | 21.46 | 20.65 | 38.94 | 65.25 |
| 消化系统药(%) | 83.99 | 84.41 | 84.32 | 92.28 |
| 其他主营业务(%) | - | - | - | 92.28 |
| 其他产品(%) | 92.66 | 92.72 | 93.84 | 97.61 |
| 其他业务(%) | - | - | - | 32.94 |
| 收入构成(%) | ||||
| 肠外营养药(%) | 17.81 | 21.86 | 29.65 | 24.03 |
| 抗感染药(%) | 52.07 | 45.79 | 26.18 | 21.88 |
| 消化系统药(%) | 5.82 | 6.65 | 12.64 | 14.04 |
| 其他主营业务(%) | - | - | - | 14.04 |
| 其他产品(%) | 24.30 | 25.70 | 31.53 | 24.94 |
| 其他业务(%) | - | - | - | 1.07 |
| 毛利构成(%) | ||||
| 肠外营养药(%) | 19.24 | 21.82 | 26.69 | 23.09 |
| 抗感染药(%) | 23.39 | 19.00 | 14.82 | 16.92 |
| 消化系统药(%) | 10.24 | 11.28 | 15.49 | 15.36 |
| 其他主营业务(%) | - | - | - | 15.36 |
| 其他产品(%) | 47.13 | 47.90 | 43.01 | 28.86 |
| 其他业务(%) | - | - | - | 0.42 |